Literature DB >> 9822625

Expression cloning and functional characterization of human cDNA for ganglioside GM3 synthase.

A Ishii1, M Ohta, Y Watanabe, K Matsuda, K Ishiyama, K Sakoe, M Nakamura, J Inokuchi, Y Sanai, M Saito.   

Abstract

Ganglioside GM3 is a major glycosphingolipid in the plasma membrane and is widely distributed in vertebrates. We describe here the isolation of a human cDNA whose protein product is responsible for the synthesis of GM3. The cloned cDNA spanned 2,359 base pairs, with an open reading frame encoding a protein of 362 amino acids with a predicted molecular mass of 41.7 kDa. The deduced primary structure shows features characteristic of the sialyltransferase family, including a type II transmembrane topology and the sialylmotifs L at the center and S at the C-terminal region. An amino acid substitution from aspartic acid to histidine was demonstrated at a position invariant in sialylmotif L of all the other sialyltransferases so far cloned. The best acceptor substrate for the gene product was lactosylceramide, and cells transfected with the cloned cDNA clearly exhibited de novo synthesis of GM3, with a measurable decrease in the precursor lactosylceramide. Despite the ubiquitous distribution of ganglioside GM3 in human tissues, a major 2.4-kilobase transcript of the gene was found in a tissue-specific manner, with predominant expression in brain, skeletal muscle, and testis, and very low expression in liver.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822625     DOI: 10.1074/jbc.273.48.31652

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  A ganglioside-specific sialyltransferase localizes to axons and non-Golgi structures in neurons.

Authors:  C A Stern; M Tiemeyer
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

Review 2.  Sialyltransferases in cancer.

Authors:  F Dall'Olio; M Chiricolo
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

3.  Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status.

Authors:  Merrina Anugraham; Francis Jacob; Sheri Nixdorf; Arun Vijay Everest-Dass; Viola Heinzelmann-Schwarz; Nicolle H Packer
Journal:  Mol Cell Proteomics       Date:  2014-05-22       Impact factor: 5.911

4.  Identification of a new liver-specific c-type mRNA transcriptional variant for mouse ST3GAL5 (GM3/GM4 synthase).

Authors:  Fumi Shishido; Satoshi Uemura; Takahiro Nitta; Jin-Ichi Inokuchi
Journal:  Glycoconj J       Date:  2017-08-14       Impact factor: 2.916

5.  Combinatorial PCR approach to homology-based cloning: cloning and expression of mouse and human GM3-synthase.

Authors:  D Kapitonov; E Bieberich; R K Yu
Journal:  Glycoconj J       Date:  1999-07       Impact factor: 2.916

6.  Harnessing the power of yeast to elucidate the role of sphingolipids in metabolic and signaling processes pertinent to psychiatric disorders.

Authors:  Shyamalagauri Jadhav; Miriam L Greenberg
Journal:  Clin Lipidol       Date:  2014-11-01

7.  Glycosphingolipid deficiency affects functional microdomain formation in Lewis lung carcinoma cells.

Authors:  J I Inokuchi; S Uemura; K Kabayama; Y Igarashi
Journal:  Glycoconj J       Date:  2000 Mar-Apr       Impact factor: 2.916

8.  Quantitative transcriptomic profiling of branching in a glycosphingolipid biosynthetic pathway.

Authors:  Hiromu Takematsu; Harumi Yamamoto; Yuko Naito-Matsui; Reiko Fujinawa; Kouji Tanaka; Yasushi Okuno; Yoshimasa Tanaka; Mamoru Kyogashima; Reiji Kannagi; Yasunori Kozutsumi
Journal:  J Biol Chem       Date:  2011-06-10       Impact factor: 5.157

9.  Identification of seven new alpha2,3-sialyltransferase III, ST3Gal III, transcripts from human foetal brain.

Authors:  Ammi Grahn; Giti Shah Barkhordar; Göran Larson
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

10.  Mucin-type O-glycans in tears of normal subjects and patients with non-Sjögren's dry eye.

Authors:  Ana Guzman-Aranguez; Flavio Mantelli; Pablo Argüeso
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04-30       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.